Home > Insider Trading > Filing (0001209191-21-012355)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
875320	Vertex Pharmaceuticals Inc / Ma	VRTX	Pharmaceutical Preparations (2834)	043039129

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1446372	M Paul Silva	C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210	Svp & Chief Accounting Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2021-02-17	2,740	$211.75	21,123	No	4	F	Direct
Common Stock	Disposition	2021-02-18	584	$210.05	20,539	No	4	S	Direct
Common Stock	Disposition	2021-02-18	2,343	$211.82	18,196	No	4	S	Direct
Common Stock	Disposition	2021-02-18	1,368	$212.62	16,828	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	F	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	169	Indirect	401(k)

Footnotes

Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $210.05 (range $209.59 to $210.37).
Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $211.82 (range $211.15 to $212.14).
Open market sales reported on this line occurred at a weighted average price of $212.62 (range $212.15 to $213.14).